• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Zimmer Biomet wins FDA clearance for shoulder replacement system

Zimmer Biomet wins FDA clearance for shoulder replacement system

September 20, 2022 By Sean Whooley

Zimmer Biomet marketing image of the reverse prosthesis version of the Identity shoulder system
The reverse prosthesis version of the Identity shoulder system [Image courtesy of Zimmer Biomet]
Zimmer Biomet (NYSE:ZBH) announced today that it received FDA 510(k) clearance for its Identity shoulder system.

Warsaw, Indiana-based Zimmer Biomet designed Identity for anatomic, reverse and revision shoulder replacement.

Identity is a convertible system that uses proprietary technologies, the company said. It aligns each surgeon’s approach to individual patient anatomy to alleviate pain and optimize range of motion. Zimmer Biomet said it designed Identity to allow surgeons to devise and execute patient-specific plans precisely.

“The FDA clearance of the Identity shoulder system is exciting because it offers surgeons a highly adaptable solution for anatomic, reverse and revision procedures to help patients optimize natural shoulder movement,” said Ivan Tornos, COO at Zimmer Biomet. “This significant milestone adds to progress in our growing sports medicine, extremities and trauma (S.E.T.) portfolio, a critical area of focus as we expand our position as a global leader in innovative medical technologies that maximize mobility.”

What is the Identity shoulder system?

Identity provides eight humeral tray combinations. The variety increases options for aligning the humerus with the glenoid without lengthening the arm. Zimmer Biomet said this expands on the traditional inlay and onlay reconstruction used in reverse shoulder arthroplasty.

The platform offers adaptability for potential revision procedures in the future. For example, it allows for 5mm of additional joint space below resection. The extra joint space gives surgeons more to work with if a patient requires revision in the future.

Zimmer Biomet’s Identity system utilizes the company’s proprietary Versa-Dial for infinite humeral head offset placement. In addition, it features the Alliance glenoid for a broad range of glenoid options to adapt to unique anatomies.

“The Identity shoulder system was designed to help surgeons restore center of rotation and achieve optimal range of motion after reverse shoulder replacements, a main goal of these procedures,” said Dr. William N. Levine chair of the department of orthopedic surgery at Columbia University’s College of Physicians and Surgeons, and a member of the Identity shoulder system development team. “Shoulder specialists will value this system’s adaptability and flexibility to support their unique surgical approaches and complement diverse patient anatomies.”

Filed Under: 510(k), Business/Financial News, Featured, Food & Drug Administration (FDA), Implants, News Well, Orthopedics, Regulatory/Compliance Tagged With: FDA, Zimmer Biomet

More recent news

  • Cooper Companies continues to see activist pressure to sell divisions, replace CEO
  • Cordis earns FDA nod for Selution SLR drug-eluting balloon
  • Siemens Healthineers links with Novo to advance liver fibrosis blood test
  • GE HealthCare rolls out AI software for predicting care bottlenecks
  • Wandercraft’s self-balancing Eve exoskeleton begins US launch

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy